Zymeworks Inc (ZYME)
9.20
+0.20
(+2.22%)
USD |
NASDAQ |
May 03, 16:00
9.22
+0.02
(+0.22%)
After-Hours: 20:00
Zymeworks Cash and Short Term Investments (Quarterly): 374.33M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 374.33M |
September 30, 2023 | 295.41M |
June 30, 2023 | 340.09M |
March 31, 2023 | 340.79M |
December 31, 2022 | 492.23M |
September 30, 2022 | 166.24M |
June 30, 2022 | 241.83M |
March 31, 2022 | 300.53M |
December 31, 2021 | 252.61M |
September 30, 2021 | 307.76M |
June 30, 2021 | 359.81M |
March 31, 2021 | 411.47M |
December 31, 2020 | 426.35M |
September 30, 2020 | 471.86M |
June 30, 2020 | 436.79M |
Date | Value |
---|---|
March 31, 2020 | 487.66M |
December 31, 2019 | 298.90M |
September 30, 2019 | 335.10M |
June 30, 2019 | 355.65M |
March 31, 2019 | 180.31M |
December 31, 2018 | 200.16M |
September 30, 2018 | 150.00M |
June 30, 2018 | 166.23M |
March 31, 2018 | 70.03M |
December 31, 2017 | 87.80M |
September 30, 2017 | 49.09M |
June 30, 2017 | 62.48M |
March 31, 2017 | 26.79M |
December 31, 2016 | 40.26M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
166.24M
Minimum
Sep 2022
492.23M
Maximum
Dec 2022
352.39M
Average
340.79M
Median
Mar 2023
Cash and Short Term Investments (Quarterly) Benchmarks
Emergent BioSolutions Inc | 111.70M |
MariMed Inc | 14.73M |
Viemed Healthcare Inc | 12.84M |
NovaBay Pharmaceuticals Inc | 3.13M |
Palatin Technologies Inc | 9.485M |